| Literature DB >> 20716509 |
Mélanie Lemire1, Myriam Fillion, Benoît Frenette, Annie Mayer, Aline Philibert, Carlos José Sousa Passos, Jean Rémy Davée Guimarães, Fernando Júnior Barbosa, Donna Mergler.
Abstract
BACKGROUND: Age-related cataracts (ARCs) are an important cause of blindness in developing countries. Although antioxidants may be part of the body's defense to prevent ARC, environmental contaminants may contribute to cataractogenesis. In fish-eating populations of the lower Tapajós region, elevated exposure to mercury (Hg) has been reported, and blood levels of selenium (Se) range from normal to very high (> 1,000 microg/L).Entities:
Mesh:
Substances:
Year: 2010 PMID: 20716509 PMCID: PMC2974697 DOI: 10.1289/ehp.0901284
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Characteristics of the study population.
| Characteristic | ≥ 40 to < 65 years ( | ≥ 65 years ( |
|---|---|---|
| Women, | 80 (46.8) | 16 (40.0) |
| Men, | 91 (53.2) | 24 (60.0) |
| Age, years, median (range) | 50 (40–64) | 73 (65–87) |
| Women | 49 (40–62) | 73 (65–84) |
| Men | 52 (40–64) | 71 (65–87) |
| Alcohol drinkers, | 81 (47.3) | 11 (27.5) |
| Current smokers, | 53 (31.0) | 11 (27.5) |
| ARC, | 36 (21.1) | 33 (82.5) |
| Women | 14 (17.5) | 15 (93.8) |
| Men | 22 (24.2) | 18 (75.0) |
| ARC gradation among cases, | ||
| Grade 1 | 11 (30.6) | 1 (3.0) |
| Grade 2 | 18 (50.0) | 4 (12.1) |
| Grade 3 | 3 (8.3) | 6 (18.2) |
| Grade 4 | 4 (11.1) | 22 (66.7) |
ARC prevalence considering all different grades of ARC.
Spearman’s ρ correlations (p-values) between age and biomarkers and between biomarkers.
| Biomarker | ||||
|---|---|---|---|---|
| Measure | B-Se | P-Se | B-Hg | P-Hg |
| Age, years | −0.30 (< 0.0001) | −0.29 (< 0.0001) | 0.03 (0.68) | −0.06 (0.41) |
| Biomarker | ||||
| B-Se | 0.72 (< 0.0001) | 0.16 (0.02) | −0.02 (0.82) | |
| P-Se | 0.18 (0.01) | 0.09 (0.19) | ||
| B-Hg | 0.70 (< 0.0001) | |||
ARC prevalence and crude and adjusted POR (95% CI) for ARC with respect to biomarker quartiles.
| Biomarker quartile | ||||
|---|---|---|---|---|
| Biomarker | First | Second | Third | Fourth |
| B-Se (μg/L) | 124 to < 183 | 185 to < 222 | 222 to < 294 | 287 to 1,500 |
| ARC cases/noncases ( | 25/26 | 20/34 | 11/42 | 13/40 |
| Crude POR | 1.00 | 0.61 (0.28–1.33) | 0.27 (0.12–0.65) | 0.34 (0.15–0.78) |
| Adjusted | 1.00 | 0.81 (0.27–2.41) | 0.64 (0.20–2.04) | 1.06 (0.34–3.29) |
| P-Se (μg/L) | 57 to < 110 | 110 to < 133 | 133 to < 168 | 168 to 913 |
| ARC cases/noncases ( | 29/23 | 13/40 | 16/37 | 11/42 |
| Crude POR | 1.00 | 0.26 (0.11–0.60) | 0.34 (0.15–0.77) | 0.21 (0.09–0.50) |
| Adjusted | 1.00 | 0.20 (0.06–0.64) | 0.63 (0.21–1.90) | 0.42 (0.13–1.31) |
| B-Hg (μg/L) | 4.3 to < 25 | 25 to < 44 | 44 to < 71 | 71 to 289 |
| ARC cases/noncases ( | 12/40 | 17/36 | 21/32 | 19/34 |
| Crude POR | 1.00 | 1.54 (0.66–3.74) | 2.19 (0.94–5.11) | 1.86 (0.79–4.38) |
| Adjusted | 1.00 | 4.10 (1.07–15.5) | 6.56 (1.78–24.2) | 3.29 (0.89–12.1) |
| P-Hg (μg/L) | 0.2 to < 3.3 | 3.3 to < 6.4 | 6.4 to < 11 | 11 to 40 |
| ARC cases/noncases ( | 17/34 | 19/33 | 11/43 | 22/32 |
| Crude POR | 1.00 | 1.15 (0.51–2.59) | 0.51 (0.21–1.24) | 1.38 (0.62–3.05) |
| Adjusted | 1.00 | 1.60 (0.85–5.13) | 0.97 (0.30–3.18) | 1.74 (0.56–5.40) |
Adjusted for age, sex, current smoking, alcohol consumption, and examiner team.
Adjusted PORs with respect to P-Se and B-Hg groups.
| Biomarker | ARC cases | Noncases | Adjusted POR (CI 95%) |
|---|---|---|---|
| Age ≥ 40 years | |||
| P-Se | |||
| High (≥ 110 μg/L) | 40 | 119 | 1.0 |
| Low (< 110 μg/L) | 29 | 23 | 2.69 (1.11–6.56) |
| B-Hg | |||
| Low (< 25 μg/L) | 12 | 40 | 1.0 |
| High (≥ 25 μg/L | 57 | 102 | 4.45 (1.43–13.83) |
| Combined P-Se and B-Hg | |||
| High P-Se–low B-Hg | 6 | 28 | 1.0 |
| Low P-Se–low B-Hg | 6 | 12 | 1.21 (0.17–8.51) |
| High P-Se–high B-Hg | 34 | 91 | 3.22 (0.76–13.6) |
| Low P-Se–high B-Hg | 23 | 11 | 16.4 (3.04–87.9) |
| Age ≥ 40 to < 65 years | |||
| P-Se | |||
| High (≥ 110 μg/L) | 21 | 115 | 1.0 |
| Low (< 110 μg/L) | 15 | 20 | 3.53 (1.31–9.45) |
| B-Hg | |||
| Low (< 44 μg/L) | 11 | 71 | 1.0 |
| High (≥ 44 μg/L) | 25 | 64 | 2.17 (0.88–5.55) |
| Combined P-Se and B-Hg | |||
| High P-Se–low B-Hg | 7 | 57 | 1.0 |
| Low P-Se–low B-Hg | 4 | 14 | 1.82 (0.38–8.82) |
| High P-Se–high B-Hg | 14 | 58 | 1.65 (0.54–5.07) |
| Low P-Se–high B-Hg | 11 | 6 | 11.8 (2.52–55.5) |
| Age ≥ 65 years | |||
| P-Se | |||
| High (≥ 110 μg/L) | 12 | 11 | 1.0 |
| Low (< 110 μg/L) | 10 | 7 | 2.34 (0.42–13.2) |
| B-Hg | |||
| Low (< 44 μg/L) | 12 | 11 | 1.0 |
| High (≥ 44 μg/L) | 10 | 7 | 2.27 (0.36–14.1) |
| Combined P-Se and B-Hg | |||
| High P-Se–low B-Hg | 6 | 6 | 1.0 |
| Low P-Se–low B-Hg | 6 | 5 | 1.21 (0.12–12.1) |
| High P-Se–high B-Hg | 6 | 5 | 1.32 (0.14–12.9) |
| Low P-Se–high B-Hg | 4 | 2 | 10.1 (0.49–208.4) |
Age ≥ 40 years and ≥ 40 to < 65 years, any ARC; age ≥ 65 years, grade 4 ARC only.
Age ≥ 40 years and age ≥ 40 to < 65 years, no ARC; age ≥ 65 years, no ARC or ARC < grade 4.
Adjusted for age, sex, current smoking, alcohol consumption, and examiner team.